News Breaks |
|
|
| February 14, 2013 |
| 09:02 EDT |  | ACTG | Acacia reaches settlement with Mallinckrodt over Exalgo
Actavis announced that it has reached a settlement with Mallinckrodt on outstanding patent litigation related to Actavis' generic version of the 32 mg dosage strength of Mallinckrodt's Exalgo tablets. In January of 2012, Actavis and Mallinckrodt previously settled litigation involving the 8 mg, 12 mg and 16 mg dosage strengths of the product. Under terms of the settlement agreement, Mallinckrodt has granted Actavis a royalty-free license to U.S. patents relating to Exalgo to sell Actavis' 32 mg product starting on May 15, 2014. Other details of the settlement were not disclosed. |
|
|
News For ACTG From The Last 14 Days Check below for free stories on ACTG the last two weeks. |
|
|
| May 24, 2013 |
| 06:01 EDT | | ACTG | Acacia Research enters into settlement and license agrement with Red Hat
 Subscribe for More Information |
|
| May 20, 2013 |
| 06:14 EDT | | ACTG | Acacia Research subsidiary enters into license and settlement agreement with MBO
Subscribe for More Information |
|
| 06:03 EDT | | ACTG | Acacia Research enters into license, settlement agreement with MBO Data, LLC
Subscribe for More Information |
|
| 06:02 EDT | | ACTG | Acacia Research enters into license, settlement agreement with Nextgen Internet
Subscribe for More Information |
|
| May 17, 2013 |
| 06:00 EDT | | ACTG | Acacia Research enters into license, settlement agreement with Mitel Networks
Subscribe for More Information |
|
| May 14, 2013 |
| 06:02 EDT | | ACTG | Acacia Research subsidiary enters into agreement with BAIS
Acacia Research announced that its Brandywine Communications Technologies subsidiary has entered into a license and settlement agreement with BAIS, dba Bay Area Internet Solutions. This agreement resolves patent litigation that was pending in the United States District Court for the Central District of California. |
|
|
|
|
|
